Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T55815 | Target Info | |||
Target Name | Neuronal acetylcholine receptor alpha-2 (CHRNA2) | ||||
Synonyms |
CHRNA2
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | CHRNA2 | ||||
Biochemical Class | Neurotransmitter receptor | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Neuronal acetylcholine receptor alpha-4/beta-2 (CHRNA4/B2) | Successful Target | ||||
UniProt ID | ACHA4_HUMAN-ACHB2_HUMAN | |||||
Gene Name | CHRNA4-CHRNB2 | |||||
Synonyms |
CHRN; nAChR
Click to Show/Hide
|
|||||
Representative Drug(s) | CYTISINE | Drug Info | Ki = 0.23 nM | [1] | ||
Co-Target Name | Muscarinic acetylcholine receptor M4 (CHRM4) | Successful Target | ||||
UniProt ID | ACM4_HUMAN | |||||
Gene Name | CHRM4 | |||||
Synonyms |
M4 receptor; CHRM4
Click to Show/Hide
|
|||||
Representative Drug(s) | Carbachol | Drug Info | IC50 = 0.4 nM | [2] | ||
Co-Target Name | Opioid receptor mu (MOP) | Successful Target | ||||
UniProt ID | OPRM_HUMAN | |||||
Gene Name | OPRM1 | |||||
Synonyms |
hMOP; Mu-type opioid receptor; Mu opioid receptor; Mu opiate receptor; MOR1A; MOR1; MOR-1; M-OR-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Levallorphan | Drug Info | Ki = 0.48 nM | Click to Show More | [3] | |
2 | Levallorphan | Drug Info | IC50 = 0.67 nM | [4] | ||
Co-Target Name | Opioid receptor kappa (OPRK1) | Successful Target | ||||
UniProt ID | OPRK_HUMAN | |||||
Gene Name | OPRK1 | |||||
Synonyms |
OPRK; Kappa-type opioid receptor; Kappa opioid receptor; KOR-1; KOR; K-OR-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Levallorphan | Drug Info | IC50 = 0.67 nM | [4] | ||
Co-Target Name | Muscarinic acetylcholine receptor M2 (CHRM2) | Successful Target | ||||
UniProt ID | ACM2_HUMAN | |||||
Gene Name | CHRM2 | |||||
Synonyms |
M2 receptor; CHRM2
Click to Show/Hide
|
|||||
Representative Drug(s) | Carbachol | Drug Info | IC50 = 3.8 nM | Click to Show More | [2] | |
2 | Carbachol | Drug Info | EC50 = 190 nM | [8] | ||
Co-Target Name | Muscarinic acetylcholine receptor M3 (CHRM3) | Successful Target | ||||
UniProt ID | ACM3_HUMAN | |||||
Gene Name | CHRM3 | |||||
Synonyms |
M3 receptor; CHRM3
Click to Show/Hide
|
|||||
Representative Drug(s) | Carbachol | Drug Info | EC50 = 70 nM | Click to Show More | [5] | |
2 | Carbachol | Drug Info | EC50 = 190 nM | [8] | ||
Co-Target Name | Muscarinic acetylcholine receptor (CHRM) | Successful Target | ||||
UniProt ID | ACM1_HUMAN; ACM2_HUMAN; ACM3_HUMAN; ACM4_HUMAN; ACM5_HUMAN | |||||
Gene Name | NO-GeName | |||||
Representative Drug(s) | Carbachol | Drug Info | EC50 = 100 nM | [6] | ||
Co-Target Name | Muscarinic acetylcholine receptor M1 (CHRM1) | Successful Target | ||||
UniProt ID | ACM1_HUMAN | |||||
Gene Name | CHRM1 | |||||
Synonyms |
M1 receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Carbachol | Drug Info | Ki = 170 nM | [7] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-3/beta-4 (CHRNA3/B4) | Successful Target | ||||
UniProt ID | ACHA3_HUMAN-ACHB4_HUMAN | |||||
Gene Name | CHRNA3-CHRNB4 | |||||
Synonyms |
Neuronal acetylcholine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | CYTISINE | Drug Info | Ki = 280 nM | [9] | ||
Co-Target Name | Muscarinic acetylcholine receptor M5 (CHRM5) | Successful Target | ||||
UniProt ID | ACM5_HUMAN | |||||
Gene Name | CHRM5 | |||||
Synonyms |
CHRM5
Click to Show/Hide
|
|||||
Representative Drug(s) | Carbachol | Drug Info | EC50 = 360 nM | [10] | ||
Co-Target Name | Acetylcholine receptor alpha-1/beta-1/delta/gamma (CHRNA1/CHRNA1/CHRND/CHRNG) | Co-Target | ||||
UniProt ID | ACHA_HUMAN-ACHB_HUMAN-ACHD_HUMAN-ACHG_HUMAN | |||||
Gene Name | CHRNA1-CHRNB1-CHRND-CHRNG | |||||
Representative Drug(s) | CYTISINE | Drug Info | EC50 = 11 nM | [11] | ||
Co-Target Name | Muscarinic acetylcholine receptor M1/M5 fusion protein (CHRM1-CHRM5) | Co-Target | ||||
UniProt ID | ACM1_HUMAN-ACM5_HUMAN | |||||
Gene Name | CHRM1-CHRM5 | |||||
Representative Drug(s) | Carbachol | Drug Info | EC50 = 1000 nM | [12] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4889-97. | ||||
REF 2 | Identification and characterization of m4 selective muscarinic antagonists. Bioorg Med Chem Lett. 1998 Aug 4;8(15):1991-6. | ||||
REF 3 | Generation of novel radiolabeled opiates through site-selective iodination. Bioorg Med Chem Lett. 2011 Jul 1;21(13):4001-4. | ||||
REF 4 | Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist. J Med Chem. 1989 Feb;32(2):418-21. | ||||
REF 5 | A novel class of conformationally restricted heterocyclic muscarinic agonists. J Med Chem. 1986 Jun;29(6):1004-9. | ||||
REF 6 | Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. J Med Chem. 1990 Dec;33(12):3182-9. | ||||
REF 7 | 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors. J Med Chem. 2000 Jun 29;43(13):2514-22. | ||||
REF 8 | Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity. J Med Chem. 1994 Nov 25;37(24):4085-99. | ||||
REF 9 | (+)-Laburnamine, a natural selective ligand and partial agonist for the alpha42 nicotinic receptor subtype. J Nat Prod. 2013 Apr 26;76(4):727-31. | ||||
REF 10 | Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors. J Med Chem. 1995 Jun 9;38(12):2188-95. | ||||
REF 11 | Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1221-4. | ||||
REF 12 | Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras. J Med Chem. 2006 Dec 14;49(25):7518-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.